Jungheinrich AG
Jungheinrich AG (JGHHY) Financial Performance & Income Statement Overview
Explore the financials of Jungheinrich AG (JGHHY), including yearly and quarterly data on income, cash flow, and balance sheets.
Jungheinrich AG (JGHHY) Income Statement & Financial Overview
Analyze Jungheinrich AG’s JGHHY earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.30B | $2.77B | $1.30B | $2.62B |
| Cost of Revenue | $0.00 | $1.89B | $0.00 | $1.78B |
| Gross Profit | $1.30B | $881.83M | $1.30B | $844.10M |
| Gross Profit Ratio | $1.00 | $0.32 | $1.00 | $0.32 |
| R&D Expenses | $0.00 | $70.64M | $0.00 | $65.10M |
| SG&A Expenses | $0.00 | $595.88M | $0.00 | $571.20M |
| Operating Expenses | $1.30B | $666.52M | $244.00M | $636.30M |
| Total Costs & Expenses | $1.30B | -$2.55B | $244.00M | $2.41B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $17.55M | $0.00 | $12.90M |
| Depreciation & Amortization | $0.00 | $237.25M | $22.32M | $111.65M |
| EBITDA | $0.00 | $450.45M | $1.08B | $222.75M |
| EBITDA Ratio | $0.00 | $0.16 | $0.83 | $0.08 |
| Operating Income | $0.00 | $215.31M | $1.06B | $209.70M |
| Operating Income Ratio | $0.00 | $0.08 | $0.81 | $0.08 |
| Other Income/Expenses (Net) | $97.10M | -$19.66M | -$957.00M | -$103.70M |
| Income Before Tax | $97.10M | $195.65M | $100.00M | $106.00M |
| Income Before Tax Ratio | $0.07 | $0.07 | $0.08 | $0.04 |
| Income Tax Expense | $0.00 | $56.35M | $29.00M | $30.80M |
| Net Income | $68.90M | $145.89M | $71.00M | $75.20M |
| Net Income Ratio | $0.05 | $0.05 | $0.05 | $0.03 |
| EPS | $0.68 | $1.43 | $0.70 | $0.74 |
| Diluted EPS | $0.68 | $1.43 | $0.70 | $0.74 |
| Weighted Avg Shares Outstanding | $102.00M | $102.00M | $102.000M | $102.000M |
| Weighted Avg Shares Outstanding (Diluted) | $102.00M | $102.00M | $102.00M | $102.00M |
The company's financials show resilient growth, with revenue advancing from $2.62B in Q2 2024 to $1.30B in Q1 2025. Gross profit remained healthy with margins at 100% in Q1 2025 compared to 32% in Q2 2024. Operating income hit $0.00 last quarter, sustaining a consistent N/A margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $0.00. Net income dropped to $68.90M, while earnings per share reached $0.68. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan